Survey reveals what older adults think about quitting daily pills
NCT ID NCT06698770
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study surveyed 2,400 adults aged 65 and older in the United States and Australia. Participants read a fictional patient scenario and shared their preferences about starting or stopping a diabetes medication. The goal was to understand how older adults make decisions about deprescribing—safely reducing or stopping medications that may no longer be needed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could help doctors have better conversations with older patients about safely reducing or stopping unnecessary medications.
What could go wrong
This was an online survey using hypothetical scenarios, not a real-world treatment trial. The findings may not reflect actual patient decisions in clinical settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESCRIBING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States